Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Sci Rep ; 11(1): 13374, 2021 06 28.
Article in English | MEDLINE | ID: mdl-34183713

ABSTRACT

Toll-like receptor (TLR) family signature has been implicated in sepsis etiopathology. We aimed to evaluate the genetic profile of TLR pathway-related key genes; the myeloid differentiation protein 88 (MYD88), IL1 receptor-associated kinase 1 (IRAK1), the nuclear factor kappa-B1 (NFKB1), and interleukin 6 (IL6) in the blood of neonates with sepsis at the time of admission and post-treatment for the available paired-samples. This case-control study included 124 infants with sepsis admitted to the neonatal intensive care unit and 17 controls. The relative gene expressions were quantified by TaqMan Real-Time qPCR and correlated to the clinic-laboratory data. MYD88, NFKB1, and IL6 relative expressions were significantly higher in sepsis cases than controls. Higher levels of MYD88 and IL6 were found in male neonates and contributed to the sex-based separation of the cases by the principal component analysis. ROC analysis revealed MYD88 and NFKB1 transcripts to be good biomarkers for sepsis. Furthermore, patients with high circulatory MYD88 levels were associated with poor survival, as revealed by Kaplan-Meier curves analysis. MYD88, NFKB1, and IL6 transcripts showed association with different poor-outcome manifestations. Clustering analysis split the patient cohort into three distinct groups according to their transcriptomic signature and CRP levels. In conclusion, the study TLR pathway-related transcripts have a gender-specific signature, diagnostic, and prognostic clinical utility in neonatal sepsis.


Subject(s)
Interleukin-6/blood , Myeloid Differentiation Factor 88/blood , NF-kappa B p50 Subunit/blood , Neonatal Sepsis/blood , Neonatal Sepsis/mortality , Biomarkers/blood , Case-Control Studies , Cohort Studies , Female , Humans , Infant, Newborn , Male , Neonatal Sepsis/pathology , Prognosis , Signal Transduction/genetics
2.
PLoS One ; 15(5): e0233737, 2020.
Article in English | MEDLINE | ID: mdl-32470060

ABSTRACT

Inflammation has received considerable attention in the pathogenesis of type 2 diabetes mellitus (T2DM). Supporting this concept, enhanced expression of interleukin (IL)-1ß and increased infiltration of macrophages are observed in pancreatic islets of patients with T2DM. Although IL-1 receptor antagonist (IL-1Ra) plays a major role in controlling of IL-1ß-mediated inflammation, its counteraction effects and epigenetic alterations in T2DM are less studied. Thus, we aimed to analyze the DNA methylation status in IL1RN, RELA (p65) and NFKB1 (p50) genes in peripheral blood mononuclear cells (PBMCs) from treated T2DM patients (n = 35) and age-/sex- matched healthy controls (n = 31). Production of IL-1ß and IL-1Ra was analyzed in plasma and supernatants from LPS-induced PBMCs. Immunomodulatory effects of IL-1ß and IL-1Ra were studied on THP-1 cells. Average DNA methylation level of IL1RN and NFKB1 gene promoters was significantly decreased in T2DM patients in comparison with healthy controls (P< 0.05), which was associated with the increased IL-1Ra (P< 0.001) and IL-1ß (P = 0.039) plasma levels in T2DM patients. Negative association between average methylation of IL1RN gene and IL-1Ra plasma levels were observed in female T2DM patients. Methylation of NFKB1 gene was negatively correlated with IL-1Ra levels in the patients and positively with IL-1ß levels in female patients. LPS-stimulated PBMCs from female patients failed to raise IL-1ß production, while the cells from healthy females increased IL-1ß production in comparison with unstimulated cells (P< 0.001). Taken together, the findings suggest that hypomethylation of IL1RN and NFKB1 gene promoters may promote the increased IL-1ß/IL-1Ra production and regulate chronic inflammation in T2DM. Further studies are necessary to elucidate the causal direction of these associations and potential role of IL-1Ra in anti-inflammatory processes in treated patients with T2DM.


Subject(s)
Diabetes Mellitus, Type 2/immunology , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-1beta/metabolism , NF-kappa B p50 Subunit/metabolism , Pancreatitis, Chronic/immunology , Adult , Aged , DNA Methylation , Diabetes Mellitus, Type 2/pathology , Female , Humans , Interleukin 1 Receptor Antagonist Protein/blood , Male , Middle Aged , NF-kappa B p50 Subunit/blood , Pancreatitis, Chronic/etiology , THP-1 Cells
3.
J Zhejiang Univ Sci B ; 19(11): 853-862, 2018.
Article in English | MEDLINE | ID: mdl-30387335

ABSTRACT

OBJECTIVE: Keloids are exuberant cutaneous scars that form due to abnormal growth of fibrous tissue following an injury. The primary aim of this study was to assess the efficacy and mechanism of hyperbaric oxygen therapy (HBOT) to reduce the keloid recurrence rate after surgical excision and radiotherapy. METHODS: (1) A total of 240 patients were randomly divided into two groups. Patients in the HBOT group (O group) received HBOT after surgical excision and radiotherapy. Patients in the other group were treated with only surgical excision and radiotherapy (K group). (2) Scar tissue from recurrent patients was collected after a second operation. Hematoxylin and eosin (H&E) staining was used to observe keloid morphology. Certain inflammatory factors (interleukin-6 (IL-6), hypoxia-inducible factor-1α (HIF-1α), tumor necrosis factor-α (TNF-α), nuclear factor κB (NF-κB), and vascular endothelial growth factor (VEGF)) were measured using immunohistochemical staining. RESULTS: (1) The recurrence rate of the O group (5.97%) was significantly lower than that of the K group (14.15%), P<0.05. Moreover, patients in the O group reported greater satisfaction than those in the K group (P<0.05). (2) Compared with the recurrent scar tissue of the K group, the expression levels of the inflammatory factors were lower in the recurrent scar tissue of the O group. CONCLUSIONS: Adjunctive HBOT effectively reduces the keloid recurrence rate after surgical excision and radiotherapy by improving the oxygen level of the tissue and alleviating the inflammatory process.


Subject(s)
Hyperbaric Oxygenation , Keloid/pathology , Keloid/radiotherapy , Keloid/surgery , Adolescent , Adult , Female , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/blood , Inflammation , Interleukin-6/blood , Male , Middle Aged , NF-kappa B p50 Subunit/blood , Perfusion , Recurrence , Surveys and Questionnaires , Tumor Necrosis Factor-alpha/blood , Vascular Endothelial Growth Factor A/blood , Young Adult
4.
PLoS One ; 13(7): e0200489, 2018.
Article in English | MEDLINE | ID: mdl-29990354

ABSTRACT

BACKGROUND/OBJECTIVES: Given their role in female reproduction, the effects of progesterone on arginine and related amino acids, polyamines and NF-κB p65 activation were studied across the menstrual cycle. METHODS: Arginine, ornithine and citrulline as well as putrescine, spermidine, spermine, and N-acetyl-putrescine were determined in plasma, NF-κB p65 activation in peripheral blood mononuclear cells and progesterone in serum of 28 women at early (T1) and late follicular (T2) and mid (T3) and late (T4) luteal phase. RESULTS: Arginine and related amino acids declined from T1 and T2 to T3 and T4, while progesterone increased. At T3, arginine, ornithine, and citrulline were inversely related with progesterone. Changes (ΔT3-T2) in arginine, ornithine, and citrulline were inversely related with changes (ΔT3-T2) in progesterone. Ornithine and citrulline were positively related with arginine, as were changes (ΔT3-T2) in ornithine and citrulline with changes (ΔT3-T2) in arginine. At T2, NF-κB p65 activation was positively related with arginine. Polyamines did not change and were not related to progesterone. All results described were significant at P < 0.001. CONCLUSIONS: This study for the first time provides data, at the plasma and PBMC level, supporting a proposed regulatory node of arginine and related amino acids, progesterone and NF-κB p65 at luteal phase of the menstrual cycle, aimed at successful preparation of pregnancy.


Subject(s)
Arginine/blood , Luteal Phase/blood , Progesterone/physiology , Adult , Amino Acids/blood , Citrulline/metabolism , Female , Follicular Phase , Healthy Volunteers , Humans , Leukocytes, Mononuclear/cytology , NF-kappa B p50 Subunit/blood , Ornithine/metabolism , Putrescine/metabolism , Reference Values , Spermidine/metabolism , Spermine/metabolism , Transcription Factor RelA/blood
5.
J Int Med Res ; 46(10): 4092-4099, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30014762

ABSTRACT

Background To investigate the relationship between the levels of nuclear factor (NF)-κB p50 and NF-κB p65 and tumour characteristics in patients with thyroid carcinoma. Methods This prospective study enrolled consecutive patients with thyroid carcinoma. Tumour samples were collected and the levels of NF-κB p50 and NF-κB p65 protein and mRNA were measured using immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). Results A total of 73 patients with thyroid carcinoma were included in the study (20 males; 53 females; mean ± SD age, 44.8 ± 12.7 years, range, 18-76 years). There were no significant differences in sex, age and pathological type between the NF-κB p50 positive group and the NF-κB p50 negative group, but tumour diameter and lymph node metastasis were significantly higher in the NF-κB p50 positive group compared with the NF-κB p50 negative group. Similar findings were observed for NF-κB p65. The levels of NF-κB p50 were positively correlated with NF-κB p65 in samples of thyroid carcinoma ( rs = 0.653). Conclusion The levels of NF-κB p50 and NF-κB p65 in samples of thyroid carcinoma were positively associated with tumour diameter and the presence of lymph node metastasis.


Subject(s)
NF-kappa B p50 Subunit/blood , Thyroid Neoplasms/blood , Thyroid Neoplasms/pathology , Transcription Factor RelA/blood , Adolescent , Adult , Aged , China , Female , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Prospective Studies , RNA, Messenger/blood , Reverse Transcriptase Polymerase Chain Reaction , Thyroid Neoplasms/metabolism , Young Adult
6.
J Strength Cond Res ; 32(6): 1601-1612, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28930874

ABSTRACT

McKinley-Barnard, SK, Andre, TL, Gann, JJ, Hwang, PS, and Willoughby, DS. Effectiveness of fish oil supplementation in attenuating exercise-induced muscle damage in females during midfollicular and midluteal menstrual phases. J Strength Cond Res 32(6): 1601-1612, 2018-The purpose of this study was to determine whether the differences in estrogen levels during the female menstrual cycle and fish oil supplementation would attenuate eccentric exercise-induced muscle damage and delayed-onset muscle soreness (DOMS). In a double-blind fashion, 22 physically active females (20.9 ± 1.4 years, 63.5 ± 9.0 kg, 165.2 ± 7.5 cm) were randomly assigned to ingest either 6 g of fish oil (n = 11) or placebo (n = 11) daily for 21 days. Participants underwent an eccentric exercise bout of the knee extensors on 2 occasions during the midfollicular (MF) and midluteal (ML) phases of the 28-day menstrual cycle. Before (PRE), at 6 (6HRPOST), and at 24 hours postexercise (24HRPOST) for each session, participants underwent assessments of DOMS, muscle strength, and had venous blood samples and muscle biopsies obtained. Data were analyzed using a 2 × 2 × 3 repeated-measures multivariate analysis of variance for each criterion variable (p ≤ 0.05). Further analysis of the main effects for the test was performed using separate 1-way analyses of variance. Delayed-onset muscle soreness was significantly greater at the 6HRPOST and 24HRPOST timepoints compared with PRE (p < 0.001). Superoxide dismutase and tumor necrosis factor-alpha (TNF-α) concentrations were significantly higher at the MF phase compared with the ML phase (p < 0.001 and p = 0.05, respectively). There were no statistically significant differences observed for muscle strength, myoglobin, NF-Kß p50, or NF-Kß p65. This study demonstrates that higher levels of estrogen may exert a cytoprotective effect on the sarcolemma.


Subject(s)
Exercise , Fish Oils/therapeutic use , Follicular Phase/blood , Luteal Phase/blood , Myalgia/prevention & control , Quadriceps Muscle/pathology , Adult , Biopsy , Dietary Supplements , Double-Blind Method , Estradiol/blood , Female , Humans , Male , Muscle Strength , Myalgia/etiology , Myoglobin/blood , NF-kappa B p50 Subunit/blood , Quadriceps Muscle/physiology , Superoxide Dismutase/blood , Transcription Factor RelA/blood , Tumor Necrosis Factor-alpha/blood , Young Adult
7.
Article in English | WPRIM (Western Pacific) | ID: wpr-1010426

ABSTRACT

OBJECTIVE@#Keloids are exuberant cutaneous scars that form due to abnormal growth of fibrous tissue following an injury. The primary aim of this study was to assess the efficacy and mechanism of hyperbaric oxygen therapy (HBOT) to reduce the keloid recurrence rate after surgical excision and radiotherapy.@*METHODS@#(1) A total of 240 patients were randomly divided into two groups. Patients in the HBOT group (O group) received HBOT after surgical excision and radiotherapy. Patients in the other group were treated with only surgical excision and radiotherapy (K group). (2) Scar tissue from recurrent patients was collected after a second operation. Hematoxylin and eosin (H&E) staining was used to observe keloid morphology. Certain inflammatory factors (interleukin-6 (IL-6), hypoxia-inducible factor-1α (HIF-1α), tumor necrosis factor-α (TNF-α), nuclear factor κB (NF-κB), and vascular endothelial growth factor (VEGF)) were measured using immunohistochemical staining.@*RESULTS@#(1) The recurrence rate of the O group (5.97%) was significantly lower than that of the K group (14.15%), P<0.05. Moreover, patients in the O group reported greater satisfaction than those in the K group (P<0.05). (2) Compared with the recurrent scar tissue of the K group, the expression levels of the inflammatory factors were lower in the recurrent scar tissue of the O group.@*CONCLUSIONS@#Adjunctive HBOT effectively reduces the keloid recurrence rate after surgical excision and radiotherapy by improving the oxygen level of the tissue and alleviating the inflammatory process.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Middle Aged , Young Adult , Hyperbaric Oxygenation , Hypoxia-Inducible Factor 1, alpha Subunit/blood , Inflammation , Interleukin-6/blood , Keloid/surgery , NF-kappa B p50 Subunit/blood , Perfusion , Recurrence , Surveys and Questionnaires , Tumor Necrosis Factor-alpha/blood , Vascular Endothelial Growth Factor A/blood
8.
Lab Med ; 49(1): 11-17, 2017 Dec 22.
Article in English | MEDLINE | ID: mdl-29069487

ABSTRACT

OBJECTIVE: Rheumatoid arthritis (RA) is a systemic and autoimmune disorder whose primary characteristic is the chronic inflammation of joints. The objective of this study was to evaluate whether there was an association between nuclear factor kappa beta1/IKK epsilon (NF-κB1/IKKε) gene expression and clinical activity in RA. METHODS: Sixty patients with RA were included in the study: 30 with clinical activity and 30 with clinical remission. NF-κB1/IKKε gene expression was performed by real-time quantitative polymerase chain reaction through relative quantification with Taqman probes. A ROC curve for NF-κB1 and IKKε was also constructed. RESULTS: There were significant differences in NF-κB1 and IKKε gene expression (P ≤ .001 and P ≤ .029, respectively) between RA patients with clinical activity and clinical remission. The multivariate lineal general model showed that the use of nonsteroidal anti-inflammatory drugs influenced the NF-κB1 (P = .046) and IKKε (P = .005) expression. The ROC curves for the event "clinical activity" showed the greater area under the curve for NF-κB1 (0.827, 95% CI 0.717-0.937), P ≤ .001. CONCLUSION: Although the use of NSAIDs influences the NF-κB1/IKKε pathway, the IKKε expression might be a useful laboratorial analysis to evaluate the RA clinical activity.


Subject(s)
Arthritis, Rheumatoid/metabolism , I-kappa B Kinase/metabolism , NF-kappa B p50 Subunit/metabolism , Adult , Arthritis, Rheumatoid/epidemiology , Arthritis, Rheumatoid/genetics , Cross-Sectional Studies , Female , Humans , I-kappa B Kinase/blood , I-kappa B Kinase/genetics , Lymphocytes/chemistry , Lymphocytes/metabolism , Male , Middle Aged , NF-kappa B p50 Subunit/blood , NF-kappa B p50 Subunit/genetics , ROC Curve , Real-Time Polymerase Chain Reaction
9.
Liver Transpl ; 23(6): 791-803, 2017 06.
Article in English | MEDLINE | ID: mdl-28407355

ABSTRACT

Hepatic ischemia/reperfusion injury (IRI) and associated inflammation contributes to liver dysfunction and complications after liver surgery and transplantation. Mesenchymal stem cells (MSCs) have been reported to reduce hepatic IRI because of their reparative immunomodulatory effects in injured tissues. Recent studies have highlighted beneficial effects of extracellular vesicles from mesenchymal stem cells (MSC-EV) on tissue injury. The effects of systemically administered mouse bone marrow-derived MSC-EV were evaluated in an experimental murine model of hepatic IRI induced by cross-clamping the hepatic artery and portal vein for 90 minutes followed by reperfusion for periods of up to 6 hours. Compared with controls, intravenous administration of MSC-EV 30 minutes prior to IRI dramatically reduced the extent of tissue necrosis, decreased caspase 3-positive and apoptotic cells, and reduced serum aminotransferase levels. MSC-EV increased hepatic messenger RNA (mRNA) expression of NACHT, LRR, and PYD domains-containing protein 12, and the chemokine (C-X-C motif) ligand 1, and reduced mRNA expression of several inflammatory cytokines such as interleukin 6 during IRI. MSC-EV increased cell viability and suppressed both oxidative injury and nuclear factor kappa B activity in murine hepatocytes in vitro. In conclusion, the administration of extracellular vesicles derived from bone marrow-derived MSCs may ameliorate hepatic IRI by reducing hepatic injury through modulation of the inflammatory response.Liver Transplantation 23 791-803 2017 AASLD.


Subject(s)
Bone Marrow Cells/cytology , Extracellular Vesicles , Liver/pathology , Mesenchymal Stem Cells/cytology , Reperfusion Injury/therapy , Animals , Apoptosis , Caspase 3/metabolism , Cell Survival , Chemokine CXCL1/blood , Hepatic Artery/pathology , Hepatocytes/cytology , Hypoxia , Inflammation , Interleukin-6/blood , Intracellular Signaling Peptides and Proteins/blood , Mesenchymal Stem Cell Transplantation , Mice , Mice, Inbred C57BL , NF-kappa B p50 Subunit/blood , Necrosis , Oxidative Stress , Oxygen/chemistry , Oxygen/metabolism , Portal Vein/pathology , Reactive Oxygen Species/metabolism , Reperfusion Injury/pathology , Transaminases/blood
10.
Biochem Biophys Res Commun ; 467(2): 248-53, 2015 Nov 13.
Article in English | MEDLINE | ID: mdl-26435503

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is the major health concern in Indian population. Despite of advanced treatment the mortality rate for this disease has not been improved very much. Current research focused on development of protein marker for the diagnosis and prognosis of HNSCC. The case control study was performed with 125 HNSCC patients and 104 control cases. The level of p50 and IκBα proteins in serum were evaluated at pre and post therapy by label free real time surface plasmon resonance (SPR) and western blot analysis. The serum p50 concentration were significantly (P < 0.0001) higher at the time of diagnosis i.e. pre therapy (Mean ± SD = 27.06 ± 4.88 ng/µl) as compared to controls (Mean ± SD = 16.96 ± 4.04 ng/µl) while it decline at post therapy (Mean ± SD = 21.01 ± 4.98 ng/µl). Similarly, the concentration of IκBα protein in serum were slightly higher at pre therapy (Mean ± SD = 8.33 ± 1.85 ng/µl) as compared to controls (Mean ± SD = 7.27 ± 1.84 ng/µl) and declined at post therapy (Mean ± SD = 7.09 ± 1.24 ng/µl). The level of p50 was also high at the early stage of the disease. The specificity and sensitivity of p50 proteins obtained from ROC analysis revealed the potentiality to be diagnostic protein marker for HNSCC for its accuracy in the study cohort.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/diagnosis , Head and Neck Neoplasms/blood , Head and Neck Neoplasms/diagnosis , NF-kappa B p50 Subunit/blood , Adult , Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Case-Control Studies , Early Diagnosis , Female , Gene Expression , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Humans , I-kappa B Proteins/blood , I-kappa B Proteins/genetics , Male , Middle Aged , NF-KappaB Inhibitor alpha , NF-kappa B p50 Subunit/genetics , Neoplasm Grading , Neoplasm Staging , Predictive Value of Tests , ROC Curve , Squamous Cell Carcinoma of Head and Neck
11.
Genet Test Mol Biomarkers ; 19(8): 424-30, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26053525

ABSTRACT

MiRNAs and NFKB1 are well-known immune response and inflammation regulators. MiRNA gene polymorphisms may affect miRNA biogenesis and function and, may thus, lead to changes in the expression of hundreds of genes such as NFKB1. The aim of this study was to investigate the association of Behcet's disease (BD) with NFKB1 rs28362491, pre-miRNA-146a rs2910164, and pre-miRNA-499 rs3746444 polymorphisms, as well as the analysis of their single and combined effects on its susceptibility in a Turkish population. These polymorphisms were analyzed by using the polymerase chain reaction-restriction fragment length polymorphism method in 100 BD patients and 145 healthy control subjects. The results were analyzed statistically using Pearson chi-square (χ(2)) test and Fisher's exact test (two sided). According to genotype analysis, the frequencies of ins/ins genotype and ins allele of rs28362491 were considerably higher in BD patients. Also, miRNA-499 rs3746444 homozygous (TT) genotypes exibited a significantly higher risk in patients with BD (odds ratios [OR]=3.0, 95% confidence intervals [95% CI]=1.284-7.007, p=0.017). Moreover, the frequency of T allele of rs3746444 was a risk factor for BD (OR=1.562, 95% CI=1.087-2.24, p=0.015). In addition, significant differences were found between the groups concerning miRNA-146a rs2910164 polymorphism. Homozygous CC genotype and C allele of rs2910164 polymorphism were found to be protective factors against BD. The results of the combined genotype analysis showed no notable differences between the multiple comparisons of rs28362491-rs2910164 and of rs28362491-rs3746444 in patients and control groups. Our data demonstrate that homozygous CC genotype and C allele of rs2910164 polymorphism are protective factors against BD, but rs3746444 and rs28362491 polymorphisms in miRNA-499 and in NFKB1 promoter are involved in the genetic susceptibility of BD. In addition, TT and ins/ins genotypes may influence certain proinflammatory cytokines and, may thus, play a role in the pathogenesis of BD.


Subject(s)
Behcet Syndrome/genetics , MicroRNAs/genetics , NF-kappa B p50 Subunit/genetics , Adult , Behcet Syndrome/blood , Case-Control Studies , Female , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease/genetics , Humans , Male , MicroRNAs/blood , NF-kappa B p50 Subunit/blood , Polymorphism, Single Nucleotide
12.
JAMA Intern Med ; 175(4): 494-501, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25686304

ABSTRACT

IMPORTANCE: Sleep disturbances are most prevalent among older adults and often go untreated. Treatment options for sleep disturbances remain limited, and there is a need for community-accessible programs that can improve sleep. OBJECTIVE: To determine the efficacy of a mind-body medicine intervention, called mindfulness meditation, to promote sleep quality in older adults with moderate sleep disturbances. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial with 2 parallel groups conducted from January 1 to December 31, 2012, at a medical research center among an older adult sample (mean [SD] age, 66.3 [7.4] years) with moderate sleep disturbances (Pittsburgh Sleep Quality Index [PSQI] >5). INTERVENTIONS: A standardized mindful awareness practices (MAPs) intervention (n = 24) or a sleep hygiene education (SHE) intervention (n = 25) was randomized to participants, who received a 6-week intervention (2 hours per week) with assigned homework. MAIN OUTCOMES AND MEASURES: The study was powered to detect between-group differences in moderate sleep disturbance measured via the PSQI at postintervention. Secondary outcomes pertained to sleep-related daytime impairment and included validated measures of insomnia symptoms, depression, anxiety, stress, and fatigue, as well as inflammatory signaling via nuclear factor (NF)-κB. RESULTS: Using an intent-to-treat analysis, participants in the MAPs group showed significant improvement relative to those in the SHE group on the PSQI. With the MAPs intervention, the mean (SD) PSQIs were 10.2 (1.7) at baseline and 7.4 (1.9) at postintervention. With the SHE intervention, the mean (SD) PSQIs were 10.2 (1.8) at baseline and 9.1 (2.0) at postintervention. The between-group mean difference was 1.8 (95% CI, 0.6-2.9), with an effect size of 0.89. The MAPs group showed significant improvement relative to the SHE group on secondary health outcomes of insomnia symptoms, depression symptoms, fatigue interference, and fatigue severity (P < .05 for all). Between-group differences were not observed for anxiety, stress, or NF-κB, although NF-κB concentrations significantly declined over time in both groups (P < .05). CONCLUSIONS AND RELEVANCE: The use of a community-accessible MAPs intervention resulted in improvements in sleep quality at immediate postintervention, which was superior to a highly structured SHE intervention. Formalized mindfulness-based interventions have clinical importance by possibly serving to remediate sleep problems among older adults in the short term, and this effect appears to carry over into reducing sleep-related daytime impairment that has implications for quality of life. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01534338.


Subject(s)
Fatigue/prevention & control , Meditation , Mindfulness , Quality of Life , Sleep Initiation and Maintenance Disorders/therapy , Sleep , Aged , Aged, 80 and over , Biomarkers/blood , Fatigue/etiology , Female , Humans , Inflammation/blood , Los Angeles , Male , Middle Aged , NF-kappa B p50 Subunit/blood , Severity of Illness Index , Sleep Initiation and Maintenance Disorders/blood , Sleep Initiation and Maintenance Disorders/complications , Sleep Initiation and Maintenance Disorders/psychology , Surveys and Questionnaires , Treatment Outcome
13.
Pharmacogenet Genomics ; 25(3): 126-33, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25564375

ABSTRACT

OBJECTIVE: Despite of the common usage of glucocorticoids (GCs), a significant portion of asthma patients exhibit GC insensitivity. This could be mediated by diverse mechanisms, including genomics. Recent work has suggested that measuring changes in gene expression may provide more predictive information about GC insensitivity than baseline gene expression alone, and that expression changes in peripheral blood may be reflective of those in the airway. METHODS: We performed in silico discovery using gene expression omnibus (GEO) data that evaluated GC effect on gene expression in multiple tissue types. Subsequently, candidate genes whose expression levels are affected by GC were examined in cell lines and in primary cells derived from human airway and blood. RESULTS: Through gene expression omnibus analysis, we identified interferon regulator factor 1 (IRF1), whose expression is affected by GC treatment in airway smooth muscle cells, normal human bronchial epithelial (NHBE) cells, and lymphoblastoid cell lines (LCLs). Significant IRF1 downregulation post GC exposure was confirmed in two cultured airway epithelial cell lines and primary NHBE cells (P<0.05). We observed large interindividual variation in GC-induced IRF1 expression changes among primary NHBE cells tested. Significant downregulation of IRF1 was also observed in six randomly selected LCLs (P<0.05), with variable degrees of downregulation among different samples. In peripheral blood mononuclear cells obtained from healthy volunteers, variable downregulation of IRF1 by GC was also shown. NFKB1, a gene whose expression is known to be downregulated by GC and the degree of downregulation of which is reflective of GC response, was used as a control in our study. IRF1 shows more consistent downregulation across tissue types when compared with NFKB1. CONCLUSION: Our results suggest that GC-induced IRF1 gene expression changes in peripheral blood could be used as a marker to reflect GC response in the airway.


Subject(s)
Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Interferon Regulatory Factor-1/blood , NF-kappa B p50 Subunit/blood , Biomarkers/blood , Cells, Cultured , Databases, Genetic , Down-Regulation/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Humans , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Respiratory System/cytology
14.
Reprod Sci ; 22(7): 852-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25616398

ABSTRACT

BACKGROUND: Preterm prelabor rupture of the fetal membranes (PPROM) is a significant contributor to the morbidity and mortality of preterm birth, particularly in the setting of chorioamnionitis. No sensitive or specific diagnostic or predictive test currently exists for the accurate diagnosis of chorioamnionitis. Our aim was to measure messenger RNA (mRNA) coding cytokines in the maternal blood and examine whether they were increased in association with chorioamnionitis at delivery. METHODS/RESULTS: We performed a prospective cohort study of women recruited with PPROM at a mean gestational age of 28.9 weeks at risk of developing chorioamnionitis. Blood was sampled from participants, and the expression of mRNA coding for proinflammatory genes was measured in women with and without chorioamnionitis at the time of delivery as well as gestation-matched healthy controls. Expression was measured using quantitative polymerase chain reaction (PCR) and also digital PCR. Interleukin 1ß (IL1B) mRNA expression in maternal blood was elevated in women with chorioamnionitis compared to gestation-matched controls. Importantly, among women admitted with PPROM, digital PCR confirmed a significant increase in IL1B expression in maternal blood in women with chorioamnionitis compared to women without chorioamnionitis. Polymerase chain reaction array revealed that CD14, nuclear factor of κ light polypeptide gene enhancer in B-cells 1 (NFKB1), and tumor necrosis factor receptor super family-interacting serine-threonine kinase 1 mRNA were significantly increased in women with chorioamnionitis compared to controls. Digital PCR confirmed that NFKB1 mRNA was significantly increased in patients with chorioamnionitis compared to controls and that CD14 levels increased over time in patients with PPROM having chorioamnionitis. CONCLUSION: Measuring circulating proinflammatory mRNA in women with PPROM may distinguish those with chorioamnionitis from those without, in turn providing better targeted therapies and appropriate timing of delivery.


Subject(s)
Chorioamnionitis/genetics , Cytokines/genetics , Fetal Membranes, Premature Rupture/genetics , Placental Circulation/genetics , RNA, Messenger/genetics , Adult , Biomarkers/blood , Chorioamnionitis/blood , Chorioamnionitis/diagnosis , Cohort Studies , Cytokines/blood , Female , Fetal Membranes, Premature Rupture/blood , Fetal Membranes, Premature Rupture/diagnosis , Humans , Interleukin-1beta/blood , Interleukin-1beta/genetics , Lipopolysaccharide Receptors/blood , Lipopolysaccharide Receptors/genetics , NF-kappa B p50 Subunit/blood , NF-kappa B p50 Subunit/genetics , Pregnancy , Prospective Studies , RNA, Messenger/blood , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/genetics
15.
Thorax ; 68(12): 1140-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23814167

ABSTRACT

BACKGROUND: Skeletal muscle weakness in chronic obstructive pulmonary disease (COPD) carries a poor prognosis, therefore a non-invasive marker of this process could be useful. Reduced expression of muscle-specific microRNA (myomiRs) in quadriceps muscle in patients with COPD is associated with skeletal muscle weakness and changes in muscle fibre composition. Circulating exosomal miRNAs can be measured in blood, making them candidate biomarkers of biopsy phenotype. To determine whether plasma myomiR levels were associated with fibre size or fibre proportion, we measured myomiRs in plasma from patients with COPD and healthy controls. METHODS AND RESULTS: 103 patients with COPD and 25 age-matched controls were studied. Muscle-specific miRNA was elevated in the plasma of patients with COPD and showed distinct patterns. Specifically, miR-1 was inversely associated with fat-free mass in the cohort, whereas levels of miR-499 were more directly associated with strength and quadriceps type I fibre proportion. Two miRs not restricted to muscle in origin (miR-16 and miR-122) did not differ between patients and controls. Plasma miR-499 was also associated with muscle nuclear factor κB p50 but not p65 in patients with early COPD whereas plasma inflammatory cytokines were associated with miR-206 in patients with more advanced disease. CONCLUSIONS: Plasma levels of individual myomiRs are altered in patients with COPD but alone do not predict muscle fibre size or proportion. Our findings are consistent with an increase in muscle wasting and turnover associated with the development of skeletal muscle dysfunction and fibre-type shift in patients with stable COPD.


Subject(s)
MicroRNAs/blood , Muscle Weakness/blood , Muscle Weakness/pathology , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Disease, Chronic Obstructive/complications , Quadriceps Muscle/metabolism , Aged , Biomarkers/blood , Case-Control Studies , Cytokines/blood , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Muscle Fibers, Slow-Twitch/pathology , Muscle Strength , Muscle Weakness/etiology , NF-kappa B p50 Subunit/blood , Pulmonary Disease, Chronic Obstructive/physiopathology , Transcription Factor RelA/blood
17.
Eur J Cardiothorac Surg ; 44(2): e141-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23671202

ABSTRACT

OBJECTIVES: The receptor activator of the nuclear factor kappa-B (NF-κB) ligand (RANKL), its membrane receptor RANK and its decoy receptor osteoprotegerin (OPG) are all members of the tumour necrosis factor family involved in bone metabolism and immune response. We evaluated the activation of the OPG/RANKL/RANK pathway in patients undergoing cardiac surgery with and without cardiopulmonary bypass (CPB). METHODS: Twenty consecutive patients undergoing elective coronary artery surgery were enrolled in the study and assigned either to the on-pump or to the off-pump group. Pre- and postoperative serum levels of OPG and RANKL were evaluated by enzyme-linked immunosorbent assay; gene expression of OPG, RANKL, RANK and NF-κB p50 subunits were determined by real-time polymerase chain reaction in peripheral blood T-cells and monocytes. RESULTS: Serum levels of OPG significantly increased after surgery in both groups, whereas serum levels of RANKL did not differ over time. T-cells from the on-pump group showed increased gene expression of OPG, RANKL and RANK after the intervention, whereas no mRNA variation for these genes was detected in T-cells from off-pump patients. Gene expression of p50 subunit increased in T-cells and monocytes from both groups. CONCLUSIONS: Cardiac surgery induces the activation of the OPG/RANKL/RANK pathway; both on- and off-pump procedures are associated with increased postoperative OPG serum levels and up-regulation of the NF-κB p50 subunit.


Subject(s)
Coronary Artery Bypass/methods , NF-kappa B p50 Subunit/blood , Osteoprotegerin/blood , RANK Ligand/blood , Receptor Activator of Nuclear Factor-kappa B/blood , Aged , Aged, 80 and over , Analysis of Variance , Enzyme-Linked Immunosorbent Assay , Female , Gene Expression Profiling , Humans , Male , Middle Aged , NF-kappa B p50 Subunit/genetics , Osteoprotegerin/genetics , Prospective Studies , Real-Time Polymerase Chain Reaction , Signal Transduction
18.
Eur J Endocrinol ; 168(3): 419-27, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23230212

ABSTRACT

OBJECTIVE: In patients with obesity and type 2 diabetes, the changes in insulin resistance are associated with the changes in expression of genes involved in nuclear factor-κB (NF-κB) activation in peripheral blood mononuclear cells (PBMCs). As such studies have never been carried out in patients with gestational diabetes (GDM), in this study, we evaluated the expression of genes involved in NF-κB activation and related to glucose metabolism in PBMCs obtained from pregnant women with GDM and normal glucose tolerance (NGT). DESIGN AND METHODS: RT-PCR was performed in 60 pregnant women divided into three groups: GDM at the 1st visit, i.e. in the 24th-28th weeks of gestation (GDM1), NGT at the first visit and GDM in the 29th-32nd weeks (GDM2), and NGT at both visits. The tests were repeated 3 months postpartum. RESULTS: The GDM1 group had significantly higher TLR2 (P=0.024), TLR4 (P=0.037), STAT1 (P=0.027), and CX3CL1 (P=0.017) mRNA expression, whereas the GDM2 group showed markedly lower TNFRSF1A (P=0.042), PPARG (P=0.018), STAT3 (P=0.013), and CX3CL1 (P=0.038) mRNA expression in comparison with the NGT group. The women with NGT at the 1st visit who later developed GDM had significantly higher fasting glucose (P=0.01), HOMA-IR (P=0.004), and TLR2 mRNA expression (P=0.04), as well as lower ISSI2 (P=0.01) and disposition indices, DI30 (P=0.03) and DI120 (P=0.01), than had the women who remained normoglycemic. CONCLUSIONS: Our results suggest that elevated TLR2 expression, as well as higher fasting glucose and lower compensation for increased insulin resistance, may represent early metabolic disturbances in the development of GDM.


Subject(s)
Diabetes, Gestational/blood , Diabetes, Gestational/metabolism , Gene Expression Regulation , Leukocytes, Mononuclear/metabolism , NF-kappa B p50 Subunit/blood , Toll-Like Receptor 2/metabolism , Adult , Blood Glucose/analysis , Chemokine CX3CL1/genetics , Chemokine CX3CL1/metabolism , Diabetes, Gestational/diagnosis , Early Diagnosis , Female , Humans , Insulin Resistance , NF-kappa B p50 Subunit/metabolism , PPAR gamma/genetics , PPAR gamma/metabolism , Pregnancy , Pregnancy Trimester, Second , Pregnancy Trimester, Third , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor, Type I/genetics , Receptors, Tumor Necrosis Factor, Type I/metabolism , STAT Transcription Factors/genetics , STAT Transcription Factors/metabolism , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism
19.
J Biomed Biotechnol ; 2009: 478785, 2009.
Article in English | MEDLINE | ID: mdl-19672323

ABSTRACT

The modulation of CD40L activity might represent a promising therapeutic target to reduce monocyte inflammatory functions in chronic diseases, such as rheumatoid arthritis. In the present study, we investigated the possible influence of nonsteroidal anti-inflammatory drugs (NSAIDs) on CD40L-induced monocyte survival. Monocytes were isolated from buffy coats by using Ficoll-Percoll gradients. Monocyte apoptosis was evaluated by fluorescence microscopy on cytopreps stained with acridine orange or using flow cytometry analysis of Annexin-V and Propidium Iodide staining. Akt and NF-kappaB activation was assessed using western blot. Caspase 3 activity was determined spectrophotometrically. Among different NSAIDs, only oxaprozin dose-dependently increased apoptosis of CD40L-treated monocytes. Oxaprozin pro-apoptotic activity was associated with the inhibition of CD40L-triggered Akt and NF-kappaB phosphorylation and the activation of caspase 3. In conclusion, our data suggest that oxaprozin-induced apoptosis in CD40L-treated human monocytes is associated with previously unknown cyclooxygenase (COX)-independent pathways. These intracellular proteins might be promising pharmacological targets to increase apoptosis in CD40L-treated monocytes.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Apoptosis/drug effects , CD40 Ligand/pharmacology , Monocytes/drug effects , Propionates/pharmacology , CD40 Ligand/blood , Caspase 3/metabolism , Cyclooxygenase Inhibitors/pharmacology , Humans , Inflammation/blood , Mitogen-Activated Protein Kinases/blood , Monocytes/cytology , Monocytes/metabolism , NF-kappa B p50 Subunit/blood , Oxaprozin , Phosphatidylinositol 3-Kinases/blood , Phosphorylation , Prostaglandin-Endoperoxide Synthases/blood , Proto-Oncogene Proteins c-akt/blood , Signal Transduction
20.
Article in English | MEDLINE | ID: mdl-17120754

ABSTRACT

Morphine has been reported to suppress human immune response. We aimed to observe the effects of morphine, fentanyl and tramadol on NF-kappa B and IL-2 from both laboratory and clinical perspective. Jurkat cells were incubated with ten times clinically relevant concentrations of morphine, fentanyl and tramadol before being stimulated with PMA. NF-kappa B binding activity and IL-2 levels were measured. In the clinical study, 150 consenting patients were randomized into 3 groups according to the analgesics used in them, namely, group morphine (M), group fentanyl (F) and group tramadol (T). IL-2 was measured preoperatively and 1, 3 and 24 h after operation. Consequently, NF-kappa B activation was suppressed by morphine and fentanyl but not by tramadol. IL-2 was significantly decreased by morphine and fentanyl but not by tramadol in vitro. In the PCA patients, IL-2 was decreased in group M and increased in group F postoperatively. Whereas in group T, IL-2 was unchanged 1 h after operation but was significantly elevated 3 and 24 h after operation. Our results showed that the inhibition of morphine on IL-2 was most probably related to its suppression on NF-kappa B. Fentanyl had different effects on human immune response in vitro and in vivo. Tramadol may have immune enhancing effect.


Subject(s)
Fentanyl/therapeutic use , Immunity/drug effects , Morphine/therapeutic use , Pain, Postoperative/prevention & control , Tramadol/therapeutic use , Analgesia, Patient-Controlled , Analgesics, Opioid/pharmacology , Analgesics, Opioid/therapeutic use , Female , Fentanyl/pharmacology , Humans , Interleukin-2/analysis , Interleukin-2/blood , Jurkat Cells , Male , Morphine/pharmacology , NF-kappa B p50 Subunit/analysis , NF-kappa B p50 Subunit/blood , Pain, Postoperative/blood , Pain, Postoperative/immunology , Tramadol/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...